PEN:NYSE
Penumbra Inc
$323.01
arrow_upward
+0.19%(+0.60) 1D
Oct 20, 10:03:06 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for PEN...
Open
$322.99
High
$323.52
Low
$322.43
Mkt. cap
12.72B
Avg. vol.
369.58K
Volume
9.93K
P/E ratio
79.34
52-wk high
$362.41
52-wk low
$221.26
EPS
$4.07
Beta
0.70
Shares outstanding
39.39M
No. of employees
5K
Open
$322.99
High
$323.52
Low
$322.43
Mkt. cap
12.72B
Avg. vol.
369.58K
Volume
9.93K
P/E ratio
79.34
52-wk high
$362.41
52-wk low
$221.26
EPS
$4.07
Beta
0.70
Shares outstanding
39.39M
No. of employees
5K
News stories
From web sources and news partners
Investing.com
·
11 minutes ago
FDA clears Penumbra’s CAVT technology for DVT treatment
The Capitol Forum
·
1 day ago
Boston Scientific/Penumbra: Divestiture Buyer Sought for Embolization Coils Business to Address FTC Concerns
Profile
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm.
In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end. Wikipedia
About Penumbra Inc